Search Results 471-480 of 11590 for Prolonged aPTT

1. U.S. CTEPH Registry - Mayo Clinic

   ... long-term outcomes for CTEPH patients treated with or without pulmonary endarterectomy. Furthermore, we have expanded data on alternative treatment options ...

2. A Phase 3 Study Evaluating Long-term Efficacy And Safety Of Lanifibranor In Adult Patients With (NASH) And Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage Of Liver Fibrosis - Mayo Clinic

   A Phase 3 Study Evaluating Long-term Efficacy And Safety Of Lanifibranor In Adult Patients With (NASH) And Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage Of Liver ...

3. A Study Investigating Long-term Treatment With Spesolimab In People With A Skin Disease Called Hidradenitis Suppurativa Who Completed A Previous Clinical Trial

   The primary objective of this trial is to assess the long-term safety of spesolimab in patients with HS who have completed the 1368-0052 PoCC trial and are ...

4. Atrial fibrillation ablation - Doctors & Departments - Mayo Clinic

   Long-term outcomes after ablation for paroxysmal atrial fibrillation using the second-generation cryoballoon: Final results from STOP AF Post-Approval Study.

5. Polyneuropathy Clinical Trials - Mayo Clinic Research

   The purpose of this study is to evaluate the safety and effectiveness of long-term dosing with (ALN-TTR02) patisiran in patients who have familial transthyretin ...

6. Safety And Efficacy Of Inhaled Treprostinil In Adult PH With ILD Including CPFE - Mayo Clinic

   Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB. Jacksonville ...

7. A Study Using The New TLR8 Agonist VTX-2337 And Cyclophosphamide In Treating Patients With Metastatic, Persistent, Recurrent, Or Progressive Solid Tumors - Mayo Clinic

   ... long time (persistent), come back (recurrent), or is growing, spreading, or getting worse (progressed). TLR8 Agonist VTX-2337 may stimulate the immune ...

8. A Study to Assess AC220 Given in Combination with Induction and Consolidation Therapy for Newly Diagnosed Acute Myeloid Leukemia (AML) - Mayo Clinic

   Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB. Jacksonville ...

9. Testing A Standardized Approach To Surgery And Chemotherapy For Type I Pleuropulmonary Blastoma Or The Addition Of An Anti-cancer Drug, Topotecan, To The Usual Treatment For Types II And III Pleuropulmonary Blastoma - Mayo Clinic

   ... long as they are NOT receiving anti-retroviral agents that are strong inhibitors or inducers of CYP3A4. Exclusion Criteria: Administration of prior PPB ...

10. A Study Of Acalabrutinib And Vistusertib In Subjects With Relapsed/Refractory B-cell Malignancies - Mayo Clinic

    Phase 4 trials look at long-term safety and effectiveness, after a new ... long or short QT syndrome; Brugada syndrome or known history of QTc ...